drugset / Trial / NCT01429961

Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma

NCT01429961 ↗

Phase 2 Unknown 38 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial of Palliative Chemotherapy with TS-1 and Oxaliplatin for Patients with Advanced Hepatocellular Carcinoma

Timeline

Start
2011-05
Primary completion
2013-12
Completion
2013-12

Outcome

Missed primary endpoint

paper Although this trial did not meet its primary end point PMID 29506478 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 130 mg/m2 Intravenous
Subject S-1 Small molecule 40 mg/m2 Oral